These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 11834187

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
    Ohashi Y, Nakai Y, Tanaka A, Kakinoki Y, Washio Y, Ohno Y, Yamada K, Nasako Y.
    Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
    [Abstract] [Full Text] [Related]

  • 3. Sarcoidosis following specific immunotherapy: more than just coincidence?
    El Jundi O, Karakaya G, Fuat Kalyoncu A.
    Allergol Immunopathol (Madr); 2007; 35(1):32-4. PubMed ID: 17338900
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Migen in the treatment of perennial rhinitis.
    Cooper B.
    Br J Clin Pract; 1979; 33(11-12):323-4. PubMed ID: 540088
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Topical nasal immunotherapy with Dermatophagoides pteronyssinus extract].
    Muñoz-López F, Martín Mateos A, Moreira A, Martínez Marín F.
    Allergol Immunopathol (Madr); 1994; 22(3):132-4. PubMed ID: 7976962
    [No Abstract] [Full Text] [Related]

  • 8. Immunotherapy in allergic rhinitis.
    Palma-Carlos AG, Spinola-Santos A, Ferreira MB, Santos MC, Palma-Carlos ML.
    Allerg Immunol (Paris); 2001 Oct; 33(8):323-6. PubMed ID: 11763723
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy.
    Benjaponpitak S, Oro A, Maguire P, Marinkovich V, DeKruyff RH, Umetsu DT.
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):468-75. PubMed ID: 10069882
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Current status of allergen-specific immunotherapy on perennial allergic rhinitis].
    Okano M.
    Arerugi; 2008 Feb; 57(2):79-85. PubMed ID: 18349581
    [No Abstract] [Full Text] [Related]

  • 16. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial.
    Varney VA, Tabbah K, Mavroleon G, Frew AJ.
    Clin Exp Allergy; 2003 Aug; 33(8):1076-82. PubMed ID: 12911781
    [Abstract] [Full Text] [Related]

  • 17. The future of immunotherapy with individual allergens: Immunotherapy with fungi.
    Pineda F.
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():36-38. PubMed ID: 29129403
    [No Abstract] [Full Text] [Related]

  • 18. [Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis].
    Du X, Shu C, Xu G, Ma M, Song H.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):372-3. PubMed ID: 22730824
    [Abstract] [Full Text] [Related]

  • 19. Local nasal immunotherapy for Dermatophagoides-induced rhinitis: efficacy of a powder extract.
    Andri L, Senna G, Betteli C, Givanni S, Andri G, Falagiani P.
    J Allergy Clin Immunol; 1993 May; 91(5):987-96. PubMed ID: 8491949
    [Abstract] [Full Text] [Related]

  • 20. Short-term efficacy of nasal immunotherapy.
    Palma-Carlos AG, Santos AS, Pregal A.
    Allerg Immunol (Paris); 1998 Jan; 30(1):14-7. PubMed ID: 9503098
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.